<DOC>
	<DOCNO>NCT00424606</DOCNO>
	<brief_summary>The combination taxanes , especially docetaxel , anthracycline seem important part chemotherapy regimen use adjuvant set patient early-stage node-positive breast cancer patient . Whether sequential concurrent administration drug preferable yet know , especially patient node-negative high risk tumor .</brief_summary>
	<brief_title>Epirubicin Docetaxel Combination ( ET ) Epirubicin Followed Docetaxel ( E/T ) Node Negative ( N0 ) High Risk Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Histologically cytologically confirm breast adenocarcinoma . Within 2045 day surgical excision primary tumor tumorfree operation margin ; least 10 axillary lymph node remove . Absence lymph node involvement eclosion hormone ( E &amp; H ) stain light microscopy evaluation . Premenopausal postmenopausal woman least one follow tumor characteristic require order characterize tumor high risk : Estrogen receptor ( ER ) ( ) progesterone receptor ( PR ) ( ) ; Ki67 + &gt; 30 % ; Grade III ; HER2 ( 3+ ) ( amendment 15.05.2008 woman HER2 ( 3+ ) include ) ; Perineural infiltration presence tumor emboli blood lymph vessel . Postmenopausal woman tumor 12 cm eligible tumor least 2 mentioned high risk criterion . Premenopausal postmenopausal woman tumor measure &gt; 2 cm eligible irrespectively expression adverse prognostic tumor criterion . Absence clinical radiological evidence local metastatic disease . Age &gt; 18 year . Performance status ( WHO ) &lt; 3 . Adequate bone marrow function ( absolute neutrophil count &gt; 1000/mm^3 , platelet count &gt; 100000/mm^3 , hemoglobin &gt; 9 gr/mm^3 ) . Adequate liver ( bilirubin &lt; 1.5 time upper limit normal SGOT/SGPT &lt; 2 time upper limit normal ) renal function ( creatinine &lt; 2 mg/dl ) . Adequate cardiac function ( LVEF &gt; 50 % ) . Negative pregnancy test . Informed consent . Other invasive malignancy within past 5 year except nonmelanoma skin cancer . Other concurrent uncontrolled illness could affect compliance study . Psychiatric illness social situation would preclude study compliance . Pregnant nursing woman . History allergic reaction attribute docetaxel . Other concurrent investigational agent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>High risk node negative</keyword>
</DOC>